Catalyst Wire Dossier Catalyst Wire Dossier
EMA withdrawal · 2014-03-11

EMA Application withdrawn: Winfuran — Toray International U.K. Limited

View source ↗

Summary

The EMA withdrew the application for Winfuran by Toray International U.K. Limited for a kidney disease indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Winfuran

Snippet

Status: Application withdrawn. Therapeutic area: Kidney Diseases. MAH: Toray International U.K. Limited. Decision date: 20/12/2013. Orphan medicine